Goodix Technology unveiled its Continuous Glucose Monitoring (CGM) solutions and automotive-grade Bluetooth LE SoC at the electronica China 2024. Demonstrating a dedication to innovation in sensing and wireless technology, Goodix showcased its latest offerings and commercial tasks, further driving the adoption of emerging applications in the healthcare and automotive electronics sectors. Incorporating blood glucose monitoring into compact and portable smart wearable devices is becoming a major trend.

The application provides real-time, convenient, and accurate data reports and health guidance for people monitoring their blood sugar levels. According to a recent report by Grand View Research, the global CGM device market size was approximately $4.6 billion in 2023, with an expected compound annual growth rate of 7.19% from 2024 to 2030. Targeting this emerging market, Goodix launched a one-stop solution featuring a Bluetooth LE SoC and an electrochemical Analog Front-end (AFE).

This solution enables CGM products in achieving high precision, long battery life, compact design, reducing the time to market for product development. The AFE supports electrochemical applications with up to four electrodes and offers current detection accuracy up to one-th thousandth. It also includes temperature measurement and electrode anomaly detection for enhanced functionality.

The Bluetooth LE SoC, developed for CGM applications, features multiple customized functions such as integrated a low-power switch to reduce energy consumption during ship mode. The SoC supports a wide input voltage range (1.2V-3.6V) to meet diverse product requirements. Through outstanding low-power IC design and system optimization, this solution ensures long battery life.

The ultra-small chip size with the simple BOM allows for a more compact design and lighter, more comfortable wear.